Current evidence on TNX-102 SL (cyclobenzaprine HCl sublingual) for fibromyalgia: strengths, limitations, and emerging hypotheses

Clinical Rheumatology 2026

View at publisher

Authors: André Pontes-Silva

DOI: 10.1007/s10067-025-07903-0

Cited by: 0

References: 12

Fields of Study & Subjects

Fibromyalgia and Chronic Fatigue Syndrome Research Rheumatoid Arthritis Research and Therapies Osteoarthritis Treatment and Mechanisms

References 12